Greenhouse Funds’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Greenhouse Funds’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-230,000	Closed	-$18.7M	–	41
2025 Q1	$18.7M	Sell	230,000 -20,000	-8%	-$1.79M	0.87%	32
2024 Q4	$22.5M	Buy	+250,000	New	+$24.2M	0.94%	33
2023 Q2	–	Sell	-50,000	Closed	-$3.81M	–	44
2023 Q1	$3.81M	Buy	+50,000	New	+$4.15M	0.32%	38

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Greenhouse Funds's XBI Position: Q2 2026 in Review

Greenhouse Funds reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 26% in Q2 2026, selling an estimated $22.5M and leaving 484,437 shares worth $76.7M. The position accounts for 3.92% of the portfolio, ranked #11.

Greenhouse Funds first reported a position in XBI in Q1 2025 and has held it in 6 quarters since. The position peaked at $83.8M in Q4 2025. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Greenhouse Funds held 484,437 shares of State Street SPDR S&P Biotech ETF worth $76.7M as of Q2 2026.
Greenhouse Funds sold 166,512 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $22.5M.
State Street SPDR S&P Biotech ETF made up 3.92% of Greenhouse Funds's portfolio in Q2 2026, its #11 holding.
Greenhouse Funds first reported a position in State Street SPDR S&P Biotech ETF in Q1 2025 and has held it in 6 quarters since.
Greenhouse Funds's State Street SPDR S&P Biotech ETF position peaked at $83.8M in Q4 2025.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Greenhouse Funds's 13F filing for Q2 2026, filed 14 Aug 2026.